rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2008-9-15
|
pubmed:abstractText |
The aim of this study was to evaluate the effects of a combination of folinic acid, 5-fluorouracil (5FU) and irinotecan (FOLFIRI 1) administered every 2 weeks in a population of elderly subjects with advanced colorectal cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1432-0843
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
931-6
|
pubmed:meshHeading |
pubmed-meshheading:18273618-Adenocarcinoma,
pubmed-meshheading:18273618-Aged,
pubmed-meshheading:18273618-Aged, 80 and over,
pubmed-meshheading:18273618-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18273618-Camptothecin,
pubmed-meshheading:18273618-Colorectal Neoplasms,
pubmed-meshheading:18273618-Combined Modality Therapy,
pubmed-meshheading:18273618-Diarrhea,
pubmed-meshheading:18273618-Disease-Free Survival,
pubmed-meshheading:18273618-Fluorouracil,
pubmed-meshheading:18273618-Hematologic Diseases,
pubmed-meshheading:18273618-Humans,
pubmed-meshheading:18273618-Leucovorin,
pubmed-meshheading:18273618-Myocardial Ischemia,
pubmed-meshheading:18273618-Organoplatinum Compounds,
pubmed-meshheading:18273618-Palliative Care,
pubmed-meshheading:18273618-Patient Compliance,
pubmed-meshheading:18273618-Prospective Studies,
pubmed-meshheading:18273618-Quality of Life,
pubmed-meshheading:18273618-Radiotherapy, Adjuvant,
pubmed-meshheading:18273618-Survival Analysis
|
pubmed:year |
2008
|
pubmed:articleTitle |
Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study.
|
pubmed:affiliation |
Centre Antoine-Lacassagne, 33 Ave de Valombrose, 06189, Nice Cedex 2, France. eric.francois@cal.nice.fnclcc.fr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|